Ac-Asp-Glu-Val-Asp-AFC
Ac-Asp-Glu-Val-Asp-AFC structure
|
Common Name | Ac-Asp-Glu-Val-Asp-AFC | ||
|---|---|---|---|---|
| CAS Number | 201608-14-2 | Molecular Weight | 729.612 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 1152.7±65.0 °C at 760 mmHg | |
| Molecular Formula | C30H34F3N5O13 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 650.9±34.3 °C | |
Use of Ac-Asp-Glu-Val-Asp-AFCAc-DEVD-AFC is a fluorogenic substrate (λex=400 nm, λem=530 nm). |
| Name | N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-trifluoromethylcoumarin |
|---|---|
| Synonym | More Synonyms |
| Description | Ac-DEVD-AFC is a fluorogenic substrate (λex=400 nm, λem=530 nm). |
|---|---|
| Related Catalog | |
| In Vitro | After incubation with Ac-DEVD-AFC for 1 hour, significant increase of caspase-3 activity is observed at 4 hour compare with control. There are no significant increases of caspase-3 activity in Photofrin and LPLI group. The cleavage of Ac-DEVD-AFC in response to caspase-3 activation is remarkably inhibited by shRNA-BimL transfection[1]. |
| Cell Assay | For the detection of caspase-3 activity, PBS washes cell pellets (derive from either the medium or the adherent cells) which are suspended in extract buffer [25 mM HEPES (pH7.4), 0.1% TritonX-l00, 10% glycerol, 5 mM DTT, 1mM phenylmethylsulfonyl fluoride, 10 mg/mL pepstatin, and 10 mg/mL Leupeptin] and vortexed vigorously. 20μl of extract (corresponding to 10% of the sample) are incubated with the caspase-3 fluorogenic substrates Ac-DEVD-AFC at 100 μM final concentration at room temperature, and caspase-3 activity is measured continuously by monitoring the release of fluorigenic AFC at 37°C[1]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 1152.7±65.0 °C at 760 mmHg |
| Molecular Formula | C30H34F3N5O13 |
| Molecular Weight | 729.612 |
| Flash Point | 650.9±34.3 °C |
| Exact Mass | 729.210510 |
| PSA | 287.61000 |
| LogP | 1.58 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.575 |
| Storage condition | −20°C |
| Water Solubility | H2O: 1 mg/mL |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib
Biochem. Pharmacol. 95 , 16-27, (2015) Nitrobenzoxadiazoles exert antitumor effects against vemurafenib-resistant melanoma cells by sustained activation of different MAPK pathways. |
|
|
Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.
Cancer Chemother. Pharmacol. 76 , 641-50, (2015) Transforming growth factor-β-activating kinase 1 (TAK1) has been implicated in promoting ovarian cancer progression. Here, we evaluated the anti-ovarian cancer effect of LYTAK1, a novel and specific T... |
|
|
AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
Am. J. Physiol. Endocrinol. Metab. 309 , E275-82, (2015) Adiponectin (APN) is a cardioprotective molecule. Its reduction in diabetes exacerbates myocardial ischemia/reperfusion (MI/R) injury. Although APN administration in animals attenuates MI/R injury, mu... |
| N-Acetyl-L-α-aspartyl-L-α-glutamyl-L-valyl-N-[2-oxo-4-(trifluoromethyl)-2H-chromen-7-yl]-L-α-asparagine |
| L-α-Asparagine, N-acetyl-L-α-aspartyl-L-α-glutamyl-L-valyl-N-[2-oxo-4-(trifluoromethyl)-2H-1-benzopyran-7-yl]- |
| Ac-DEVD-AFC |
| MFCD01310970 |